Alert Indications, Safety, and Warnings

Vanta™ SCS Neurostimulator  Recharge-free device

VantaTM SCS is a high-performance recharge-free device optimised for longevity1, offering personalised programming, and unmatched MRI access*.

Download Brochure
Vanta
Alert Indications, Safety, and Warnings

Overview

Vanta™ SCS recharge-free device.

Optimised for longevity1.

Product details

 

Vanta™ SCS is a high-performance recharge-free device offering optimised longevity

  • 2x longer lasting than competitive PC devices at comparable settings2,3.
  • 5½–7½ years of recharge-free longevity estimated using actual 6-month DTM™ SCS endurance therapy programming data4
  • In-app longevity estimator

SMALLER DEVICE†

  • 20% Smaller.
  • 20% Thinner.
Vanta Platform

DTM™ SCS endurance therapy

DTM™ SCS endurance therapy is an energy modified differential target multiplexed therapy offering meaningful pain relief, satisfaction, and quality of life improvements.5

SEE MORE EVIDENCE

 

Clinical evidence for DTM™ SCS endurance therapy:

Meaningful pain relief

4.1 graph

reduction in VAS for
overall pain from
baseline to 6-months

Quality of life improvements

63 percent graph

had minimal to moderate disability at 3-months compared to only 16% at baseline

Therapy satisfaction

75 percent graph

of patients were
very or somewhat
satisfied with therapy

 

Vanta™ has been enhanced for a better patient experience

Unmatched full-body
MRI access

  • SureScan™ MRI technology allows MRI scans anywhere on the body* enabling diagnostic care.
  • Provide patients the same access as non-implanted patients* — now and in the future.
  • Shielded leads and proprietary device safeguards help patients safely get an MRI.*
  • Access matters — 98% of patients are expected to need at least 1 MRI within 10 years of implant.6

Personalised programming
 

  • AdaptiveStim™ technology automatically personalises therapy to maintain the optimal dose.
  • 86.5% of patients reported better pain relief and/or convenience with AdaptiveStim™ technology over non-adaptive stimulation7.
  • Exclusively offered by Medtronic.

Product specifications

Compatible with:

  • MyStim™ PC smart patient therapy app model A72200
  • Clinician programmer model CT900 with software app A71200 and trialing app A71300
  • 16-electrode Specify™ SureScan™ MRI surgical leads
  • Vectris™ SureScan™ MRI percutaneous leads
  • INJEX™ anchoring system models 97791 and 97792

Model specifications

Model 977006 
Channels 2
Width 1.1 cm (.44in) 
Battery Type Recharge-free 
*

Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.

†

than PrimeAdvanced INS

1

The INS shall provide a minimum service life of 11 years from Beginning of Service to End of Service (EOS) for a bipolar single program with one bipolar electrode pair and stimulation settings of 1.6mA, 60µs, 130 Hz, and 550 ohms per electrode (resultant therapy power of 40µW).  977006 Vanta Implant Manual M998494A001 Rev C

2

Settings used from Abbott Proclaim™ clinician manual. Nominal settings 12 hours per day: 50-Hz frequency, 225-μs pulse width, and 5-mA amplitude at 500-ohms impedance. Compared to flagship model 3660. 

3

Settings from Boston Scientific’s Alpha™ IFU. Programmed at 4.1mA, 280us, 40 Hz, 1 area, 730 Ohms, 2 contacts.

4

Provenzano, Amirdelfan, Grewal, et al. Modeling the impact of a differential target multiplexed derivative on rechargeable and recharge-free spinal cord stimulation systems using results from the Endurance Study. Poster presented at: International Neuromodulation Society (INS) World Congress; May 21-26, 2022; Barcelona, Spain.

5

Peacock, Provenzano, Fishman, et al. A prospective multi-center study of a differential target multiplexed™ stimulation derivative in therapy-naive patients. Poster presented at: International Neuromodulation Society (INS) World Congress; May 21-26, 2022; Barcelona, Spain.

6

Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531-537

7

Schultz D, Webster L, Kosek P, et al. Sensor-driven position-adaptive spinal cord stimulation for chronic pain. Pain Physician. 2012;15(1):1-12. 977006 Vanta Implant Manual M998494A001 Rev C

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.

For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.